Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

259 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A novel serum biomarker quintet reveals added prognostic value when combined with standard clinical parameters in prostate cancer patients by predicting biochemical recurrence and adverse pathology.
Athanasiou A, Tennstedt P, Wittig A, Huber R, Straub O, Schiess R, Steuber T. Athanasiou A, et al. Among authors: steuber t. PLoS One. 2021 Nov 12;16(11):e0259093. doi: 10.1371/journal.pone.0259093. eCollection 2021. PLoS One. 2021. PMID: 34767586 Free PMC article.
Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology.
Chun FK, Steuber T, Erbersdobler A, Currlin E, Walz J, Schlomm T, Haese A, Heinzer H, McCormack M, Huland H, Graefen M, Karakiewicz PI. Chun FK, et al. Among authors: steuber t. Eur Urol. 2006 May;49(5):820-6. doi: 10.1016/j.eururo.2005.11.007. Epub 2005 Dec 22. Eur Urol. 2006. PMID: 16439050
Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation.
Chun FK, Briganti A, Shariat SF, Graefen M, Montorsi F, Erbersdobler A, Steuber T, Salonia A, Currlin E, Scattoni V, Friedrich MG, Schlomm T, Haese A, Michl U, Colombo R, Heinzer H, Valiquette L, Rigatti P, Roehrborn CG, Huland H, Karakiewicz PI. Chun FK, et al. Among authors: steuber t. BJU Int. 2006 Aug;98(2):329-34. doi: 10.1111/j.1464-410X.2006.06262.x. BJU Int. 2006. PMID: 16879673
Circulating biomarkers for prostate cancer.
Steuber T, Helo P, Lilja H. Steuber T, et al. World J Urol. 2007 Apr;25(2):111-9. doi: 10.1007/s00345-007-0160-0. Epub 2007 Mar 8. World J Urol. 2007. PMID: 17345087 Review.
Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level < or = 4.0 ng per milliliter.
Ahyai SA, Graefen M, Steuber T, Haese A, Schlomm T, Walz J, Köllermann J, Briganti A, Zacharias M, Friedrich MG, Karakiewicz PI, Montorsi F, Huland H, Chun FK. Ahyai SA, et al. Among authors: steuber t. Eur Urol. 2008 Apr;53(4):750-7. doi: 10.1016/j.eururo.2007.10.017. Epub 2007 Oct 17. Eur Urol. 2008. PMID: 17964070
259 results